Department of Pathobiology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA.
Proc Natl Acad Sci U S A. 2012 Aug 7;109(32):12998-3003. doi: 10.1073/pnas.1205854109. Epub 2012 Jul 25.
Heme insertion is key during maturation of soluble guanylyl cyclase (sGC) because it enables sGC to recognize NO and transduce its multiple biological effects. Although sGC is often associated with the 90-kDa heat shock protein (hsp90) in cells, the implications are unclear. The present study reveals that hsp90 is required to drive heme insertion into sGC and complete its maturation. We used a mammalian cell culture approach and followed heme insertion into transiently and endogenously expressed heme-free sGC. We used pharmacological hsp90 inhibitors, an ATP-ase inactive hsp90 mutant, and heme-dependent or heme-independent sGC activators as tools to decipher the role of hsp90. Our findings suggest that hsp90 complexes with apo-sGC, drives heme insertion through its inherent ATPase activity, and then dissociates from the mature, heme-replete sGC. Together, this improves our understanding of sGC maturation and reveals a unique means to control sGC activity in cells, and it has important implications for hsp90 inhibitor-based cancer therapy.
血红素插入是可溶性鸟苷酸环化酶(sGC)成熟的关键,因为它使 sGC 能够识别 NO 并传递其多种生物学效应。尽管 sGC 通常与细胞中的 90kDa 热休克蛋白(hsp90)相关联,但具体含义尚不清楚。本研究揭示 hsp90 是驱动血红素插入 sGC 并完成其成熟所必需的。我们使用哺乳动物细胞培养方法,并跟踪瞬时和内源性表达无血红素 sGC 的血红素插入。我们使用药理学 hsp90 抑制剂、ATP 酶失活 hsp90 突变体以及血红素依赖性或非血红素依赖性 sGC 激活剂作为工具来解析 hsp90 的作用。我们的研究结果表明,hsp90 与 apo-sGC 复合物,通过其内在的 ATP 酶活性驱动血红素插入,然后从成熟的血红素填充 sGC 中解离。总的来说,这提高了我们对 sGC 成熟的理解,并揭示了一种在细胞中控制 sGC 活性的独特方法,这对基于 hsp90 抑制剂的癌症治疗具有重要意义。